Citius Pharmaceuticals
CTXR
$0.70
Share price
-0.28%
Change (1 day)
-43.60%
Change (1 year)
Categories
Citius Pharmaceuticals (CTXR) - P/B ratio
P/B ratio as of May 2024 : 1.50
According to Citius Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 1.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Citius Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.41 | 23.18% |
| 2022-12-31 | 1.14 | -36.68% |
| 2021-12-31 | 1.81 | -17.83% |
| 2020-12-31 | 2.20 | 45.45% |
| 2019-12-31 | 1.51 | 97.31% |
| 2018-12-31 | 0.7656 | -38.16% |
| 2017-12-31 | 1.24 | -42.95% |
| 2016-12-31 | 2.17 | -105.38% |
| 2015-12-31 | -40.4 | 2.86% |
| 2014-12-31 | -39.2 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 91.51% | 🇺🇸 USA |